[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-ptc-therapeutics-nasdaqptct-an33019a566f-f119-73c4-baa5-c12b2109eada":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":21},"ptc-therapeutics-nasdaqptct-an33019a566f-f119-73c4-baa5-c12b2109eada","1762386607000","PTC Therapeutics (NASDAQ:PTCT) Announces Quarterly Earnings Results, Beats Expectations By $1.39 EPS","PTC Therapeutics (NASDAQ:PTCT - Get Free Report) released its earnings results on Tuesday. The biopharmaceutical company reported $0.20 earnings per share for the quarter, topping the consensus estimate of ($1.11) by $1.31. PTC Therapeutics had a net margin of 35.65% and a negative return on equity of 106.31%.","https://www.marketbeat.com/instant-alerts/ptc-therapeutics-nasdaqptct-posts-earnings-results-beats-estimates-by-131-eps-2025-11-04/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"-\",\"EPS\",\"Equity\"]","[{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"},{\"name\":\"EPS\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/eps.png\"},{\"name\":\"Equity\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/equity.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN"]